Skip to main content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Journal für Klinische Endokrinologie und Stoffwechsel 1/2023

30.12.2022 | Originalien

Hormonpumpen

verfasst von: Birgit Reinhart-Steininger, Ingrid Schütz-Fuhrmann, Thomas M. Stulnig

Erschienen in: Journal für Klinische Endokrinologie und Stoffwechsel | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Zusammenfassung

Medizinische Pumpensysteme ermöglichen die akkurate Gabe eines Medikaments in Form einer kontinuierlichen Infusion und/oder rezidivierenden Bolusgabe über einen Katheter in das subkutane Fettgewebe, nach intravenös oder auch intrathekal. Sie erleichtern den Alltag der PatientInnen, da andernfalls die häufige Selbstinjektion des Medikaments notwendig wäre, was nicht nur schmerzbehaftet sein kann, sondern tagsüber sowie unter Umständen auch nachts eine aktive Handlung des Patienten erfordert. Darüber hinaus können Hormonpumpen den physiologischen Stoffwechselprozess oft besser nachahmen, was für manche endokrine Erkrankungen eine Behandlung überhaupt erst ermöglicht. In diesem Review konzentrieren wir uns auf die Hauptanwendungsgebiete subkutaner Hormonpumpensysteme, nämlich den Diabetes mellitus Typ 1 (T1DM) sowie Anwendungen in der Gynäkologie und Reproduktionsmedizin, insbesondere bei hypothalamischer Insuffizienz.
Literatur
1.
Zurück zum Zitat Ostrovski I et al (2020) Analysis of prevalence, magnitude and timing of the dawn phenomenon in adults and adolescents with type 1 diabetes: descriptive analysis of 2 insulin pump trials. Can J Diabetes 44:229 CrossRefPubMed Ostrovski I et al (2020) Analysis of prevalence, magnitude and timing of the dawn phenomenon in adults and adolescents with type 1 diabetes: descriptive analysis of 2 insulin pump trials. Can J Diabetes 44:229 CrossRefPubMed
2.
Zurück zum Zitat Thomas A (2010) Diabetes und Technologie, Geschichte der Insulinpumpentherapie Thomas A (2010) Diabetes und Technologie, Geschichte der Insulinpumpentherapie
5.
Zurück zum Zitat Ly TT, Nicholas JA, Retterath A et al (2013) Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 310:1240–1247 CrossRefPubMed Ly TT, Nicholas JA, Retterath A et al (2013) Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 310:1240–1247 CrossRefPubMed
7.
Zurück zum Zitat Bergenstal RM et al (2013) Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 369:224–232 CrossRefPubMed Bergenstal RM et al (2013) Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 369:224–232 CrossRefPubMed
8.
Zurück zum Zitat Forlenza GP et al (2018) Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial. Diabetes Care 41:2155–2161 CrossRefPubMed Forlenza GP et al (2018) Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial. Diabetes Care 41:2155–2161 CrossRefPubMed
12.
Zurück zum Zitat Bergenstal RM et al (2016) Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA 316:1407–1408 CrossRefPubMed Bergenstal RM et al (2016) Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA 316:1407–1408 CrossRefPubMed
13.
14.
Zurück zum Zitat Lal RA, Basina M, Maahs DM et al (2019) One year clinical experience of the first commercial hybrid closed-loop system. Diabetes Care 42:2190–2196 CrossRefPubMedPubMedCentral Lal RA, Basina M, Maahs DM et al (2019) One year clinical experience of the first commercial hybrid closed-loop system. Diabetes Care 42:2190–2196 CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Garg SK et al (2017) Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther 19:155–163 CrossRefPubMedPubMedCentral Garg SK et al (2017) Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther 19:155–163 CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Ekhlaspour L et al (2022) Outcomes in baseline hemoglobin A1C subgroups in the international diabetes closed-loop 18 trial. Diabetes Technol Ther 24(8):588–591 CrossRefPubMed Ekhlaspour L et al (2022) Outcomes in baseline hemoglobin A1C subgroups in the international diabetes closed-loop 18 trial. Diabetes Technol Ther 24(8):588–591 CrossRefPubMed
20.
Zurück zum Zitat Jennings P, Hussain S (2020) Do-it-yourself artificial pancreas systems: a review of the emerging evidence and insights for healthcare professionals. J Diabetes Sci Technol 14:868–877 CrossRefPubMed Jennings P, Hussain S (2020) Do-it-yourself artificial pancreas systems: a review of the emerging evidence and insights for healthcare professionals. J Diabetes Sci Technol 14:868–877 CrossRefPubMed
21.
Zurück zum Zitat Braune K, OPEN International Healthcare Professional Network and OPEN Legal Advisory Group et al (2022) Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals. Lancet Diabetes Endocrinol 10(1):58–74. https://​doi.​org/​10.​1016/​S2213-8587(21)00267-9 (Erratum in: Lancet Diabetes Endocrinol. 2022 Jan;10(1):e1) CrossRefPubMed Braune K, OPEN International Healthcare Professional Network and OPEN Legal Advisory Group et al (2022) Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals. Lancet Diabetes Endocrinol 10(1):58–74. https://​doi.​org/​10.​1016/​S2213-8587(21)00267-9 (Erratum in: Lancet Diabetes Endocrinol. 2022 Jan;10(1):e1) CrossRefPubMed
23.
Zurück zum Zitat Castellanos LE et al (2021) Performance of the insulin-only ilet bionic pancreas 17 and the bihormonal ilet using dasiglucagon in adults with type 1 diabetes in a home-use 18 setting. Diabetes Care 44(6):e118–e120 CrossRefPubMedPubMedCentral Castellanos LE et al (2021) Performance of the insulin-only ilet bionic pancreas 17 and the bihormonal ilet using dasiglucagon in adults with type 1 diabetes in a home-use 18 setting. Diabetes Care 44(6):e118–e120 CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Haidar A et al (2020) A novel dual-20 hormone insulin-and-pramlintide artificial pancreas for type 1 diabetes: a randomized 21 controlled crossover trial. Diabetes Care 43(3):597–606 CrossRefPubMed Haidar A et al (2020) A novel dual-20 hormone insulin-and-pramlintide artificial pancreas for type 1 diabetes: a randomized 21 controlled crossover trial. Diabetes Care 43(3):597–606 CrossRefPubMed
26.
Zurück zum Zitat Holesh JE et al (2022) Physiology, ovulation. StatPearls, Treasure Island (FL) Holesh JE et al (2022) Physiology, ovulation. StatPearls, Treasure Island (FL)
27.
Zurück zum Zitat Crowley WF Jr et al (1981) Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 52:370–372 CrossRefPubMed Crowley WF Jr et al (1981) Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 52:370–372 CrossRefPubMed
28.
Zurück zum Zitat Topaloglu AK et al (2009) TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat Genet 41:354–358 CrossRefPubMed Topaloglu AK et al (2009) TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat Genet 41:354–358 CrossRefPubMed
30.
Zurück zum Zitat Whitlock KE (2005) Origin and development of GnRH neurons. Trends Endocrinol Metab 16:145–151 CrossRefPubMed Whitlock KE (2005) Origin and development of GnRH neurons. Trends Endocrinol Metab 16:145–151 CrossRefPubMed
31.
Zurück zum Zitat Schwanzel-Fukuda M (1989) Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res 6:311–326 CrossRefPubMed Schwanzel-Fukuda M (1989) Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res 6:311–326 CrossRefPubMed
32.
Zurück zum Zitat Soussi-Yanicostas N et al (1998) Anosmin‑1 underlying the X chromosome-linked Kallmann syndrome is an adhesion molecule that can modulate neurite growth in a cell-type specific manner. J Cell Sci 111(19):2953–2965 CrossRefPubMed Soussi-Yanicostas N et al (1998) Anosmin‑1 underlying the X chromosome-linked Kallmann syndrome is an adhesion molecule that can modulate neurite growth in a cell-type specific manner. J Cell Sci 111(19):2953–2965 CrossRefPubMed
33.
Zurück zum Zitat Caron P et al (1999) Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. J Clin Endocrinol Metab 84:990–996 CrossRefPubMed Caron P et al (1999) Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. J Clin Endocrinol Metab 84:990–996 CrossRefPubMed
34.
Zurück zum Zitat Sykiotis GP et al (2010) Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab 95:3019–3027 CrossRefPubMedPubMedCentral Sykiotis GP et al (2010) Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab 95:3019–3027 CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Ankarberg-Lindgren C et al (2001) Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. J Clin Endocrinol Metab 86:3039–3044 PubMed Ankarberg-Lindgren C et al (2001) Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. J Clin Endocrinol Metab 86:3039–3044 PubMed
36.
Zurück zum Zitat Bergadá I, Bergadá C (1995) Long term treatment with low dose testosterone in constitutional delay of growth and puberty: effect on bone age maturation and pubertal progression. J Pediatr Endocrinol Metab 8:117–122 CrossRefPubMed Bergadá I, Bergadá C (1995) Long term treatment with low dose testosterone in constitutional delay of growth and puberty: effect on bone age maturation and pubertal progression. J Pediatr Endocrinol Metab 8:117–122 CrossRefPubMed
37.
Zurück zum Zitat Balasubramanian R, Crowley WF Jr. (2007) Isolated gonadotropin-releasing hormone (GnRH) deficiency. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (Hrsg) GeneReviews. University of Washington, Seattle Balasubramanian R, Crowley WF Jr. (2007) Isolated gonadotropin-releasing hormone (GnRH) deficiency. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (Hrsg) GeneReviews. University of Washington, Seattle
38.
Zurück zum Zitat Martin KA et al (1993) Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 77:125–129 PubMed Martin KA et al (1993) Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 77:125–129 PubMed
39.
Zurück zum Zitat Suh BY et al (1988) Hypercortisolism in patients with functional hypothalamicamenorrhea. J Clin Endocrinol Metab 66:733–739 CrossRefPubMed Suh BY et al (1988) Hypercortisolism in patients with functional hypothalamicamenorrhea. J Clin Endocrinol Metab 66:733–739 CrossRefPubMed
41.
Zurück zum Zitat Couzinet B et al (1999) Functional hypothalamic amenorrhoea: a partial and reversible gonadotrophin deficiency of nutritional origin. Clin Endocrinol (Oxf) 50:229–235 CrossRefPubMed Couzinet B et al (1999) Functional hypothalamic amenorrhoea: a partial and reversible gonadotrophin deficiency of nutritional origin. Clin Endocrinol (Oxf) 50:229–235 CrossRefPubMed
42.
Zurück zum Zitat Bomba M et al (2007) Endocrine profiles and neuropsychologic correlates of functional hypothalamic amenorrhea in adolescents. Fertil Steril 87:876–885 CrossRefPubMed Bomba M et al (2007) Endocrine profiles and neuropsychologic correlates of functional hypothalamic amenorrhea in adolescents. Fertil Steril 87:876–885 CrossRefPubMed
43.
Zurück zum Zitat Golden NH, Carlson JL (2008) The pathophysiology of amenorrhea in the adolescent. Ann N Y Acad Sci 1135:163–178 CrossRefPubMed Golden NH, Carlson JL (2008) The pathophysiology of amenorrhea in the adolescent. Ann N Y Acad Sci 1135:163–178 CrossRefPubMed
44.
Zurück zum Zitat Gordon CM (2010) Clinical practice. Functional hypothalamic amenorrhea. N Engl J Med 363:365–371 CrossRefPubMed Gordon CM (2010) Clinical practice. Functional hypothalamic amenorrhea. N Engl J Med 363:365–371 CrossRefPubMed
46.
Zurück zum Zitat Martin KA et al (1993) Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 77:125–129 PubMed Martin KA et al (1993) Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 77:125–129 PubMed
47.
Zurück zum Zitat Dumont A et al (2016) Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology. Gynecol Endocrinol 32:999–1004 CrossRefPubMed Dumont A et al (2016) Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology. Gynecol Endocrinol 32:999–1004 CrossRefPubMed
48.
Zurück zum Zitat Wildt L et al (2019) Pulsatile GnRH-Therapie. In: Diedrich K, Ludwig M, Griesinger G (Hrsg) Reproduktionsmedizin. Springer, Berlin, Heidelberg Wildt L et al (2019) Pulsatile GnRH-Therapie. In: Diedrich K, Ludwig M, Griesinger G (Hrsg) Reproduktionsmedizin. Springer, Berlin, Heidelberg
49.
Zurück zum Zitat Begon S et al (1993) Pulsatile administration of gonadotrophin releasing hormone as a diagnostic tool to distinguish hypothalamic from pituitary hypogonadism following neurosurgery. Hum Reprod 8(2):200–203 CrossRefPubMed Begon S et al (1993) Pulsatile administration of gonadotrophin releasing hormone as a diagnostic tool to distinguish hypothalamic from pituitary hypogonadism following neurosurgery. Hum Reprod 8(2):200–203 CrossRefPubMed
51.
Zurück zum Zitat Liu Z et al (2015) Effectiveness and safety of pulsatile GnRH pump therapy on female patients with IHH. Zhonghua Yi Xue Za Zhi 95(42):3432–3435 PubMed Liu Z et al (2015) Effectiveness and safety of pulsatile GnRH pump therapy on female patients with IHH. Zhonghua Yi Xue Za Zhi 95(42):3432–3435 PubMed
53.
Zurück zum Zitat Tranoulis A et al (2018) Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis. Fertil Steril 109:708–719 CrossRefPubMed Tranoulis A et al (2018) Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis. Fertil Steril 109:708–719 CrossRefPubMed
54.
Zurück zum Zitat Filicori M et al (1991) Ovulation induction with pulsatile gonadotropin-releasing hormone: technical modalities and clinical perspectives. Fertil Steril 56:1–13 CrossRefPubMed Filicori M et al (1991) Ovulation induction with pulsatile gonadotropin-releasing hormone: technical modalities and clinical perspectives. Fertil Steril 56:1–13 CrossRefPubMed
56.
Zurück zum Zitat Filicori M et al (1994) Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab 79:1215–1220 PubMed Filicori M et al (1994) Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab 79:1215–1220 PubMed
61.
Zurück zum Zitat Pitteloud N et al (2002) Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87:4128–4136 CrossRefPubMed Pitteloud N et al (2002) Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87:4128–4136 CrossRefPubMed
62.
Zurück zum Zitat Rastrelli G et al (2014) Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology 2(6):794–808 CrossRefPubMed Rastrelli G et al (2014) Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology 2(6):794–808 CrossRefPubMed
Metadaten
Titel
Hormonpumpen
verfasst von
Birgit Reinhart-Steininger
Ingrid Schütz-Fuhrmann
Thomas M. Stulnig
Publikationsdatum
30.12.2022
Verlag
Springer Vienna
Erschienen in
Journal für Klinische Endokrinologie und Stoffwechsel / Ausgabe 1/2023
Print ISSN: 1998-7773
Elektronische ISSN: 1998-7781
DOI
https://doi.org/10.1007/s41969-022-00184-x

Weitere Artikel der Ausgabe 1/2023

Journal für Klinische Endokrinologie und Stoffwechsel 1/2023 Zur Ausgabe